Final Program [International AIDS Society (11th: 1996: Vancouver, Canada)]

VENUE ROOM TRACK SESSION NO. TIME / SESSION PATHWAYS
B2 237 Track B: Clinical Science
Hall B oAbstract Session:
North Part I: Prophylaxis of Infection
Chairs:
Clyde Crumpacker, USA / Daniel Podzamczer, Spain...............................................................................................................................................................................................................................................
Tu.B.410 15:30
PREVENTION OF PNEUMOCYSTIS CARINII PNEUMONIA WITH AZITHROMYCIN
Dunne Michael W, Havlir D, Dube M, Sattler F, Forthal D, Kemper C, McCutchan A and the 066-174 Study Investigators. Pfizer Central
Research, Groton, CT; University of California, San Diego, CA, USA................................................................................................................................................................................................................................................
Tu.B.411 I15:45
A RANDOMIZED TRIAL COMPARING FLUCONAZOLE WITH PLACEBO FOR PROPHYLAXIS OF MUCOSAL CANDIDIASIS
IN WOMEN WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION
Schuman Paula,Vazquez J, Sobel JD, Goldman A, Peng G, Capps L and the Terry Beirn Community Programs for Clinical Research on
AIDS (CPCRA)................................................................................................................................................................................................................................................
Tu.B.412 16:00
REASONS FOR FAILURE OF PREVENTION OF TOXOPLASMA ENCEPHALITIS
van Delden, Christian', Gabriel VI, Sudre PI, Flepp M2, von Overbeckj3, Hirschel B'. 'Div. of Infectious Diseases, University Hospital,
Geneva; 2University Hospital, Zurich; 3University Hospital, Lausanne, Switzerland................................................................................................................................................................................................................................................
Tu.B.413 16:15
HIV-I INFECTION IMPAIRS THE EFFICACY OF SULFADOXINE-PYRIMETHAMINE IN PREVENTION OF PLACENTAL
MALARIA INFECTION IN WESTERN KENYA
Nahlen Bernard LI, Parise ME2, Ayisi Ji, Oloo AJi, Schultz LJ2, Steketee RW2. I'Kenya Medical Research Institute, Nairobi, Kenya; 2CDC,
Atlanta, GA, USA................................................................................................................................................................................................................................................
Tu.B.414 16:30
COTRIMOXAZOLE (TMP-SMX) DESENSITIZATION USING ADJUNCTIVE STEROID THERAPY IN HIV/AIDS PATIENTS
S Beardsell, Ann DI, Coker Kl, Woodfall B2, Conway B3. St. Paul's Hospital, IPharmacy; 2Family Practice; 3BC Centre for Excellence in
c HIV/AIDS,Vancouver, BC, Canada.
(1 )...............................................................................................................................................................................................................................................
o Tu.B.415 16:45
0
S COST-EFFECTIVENESS OF PREVENTING AIDS-RELATED OPPORTUNISTIC INFECTIONS
> Freedberg, Kenneth A, Alpher JL, Seage GR, Losina E, Weinstein MC, Craven DE, Paltiel AD. Boston City Hospital, Boston University
School of Medicine, Harvard School of Public Health, Boston, MA, USA.
C
B)
cO
O
B)
C
O
u
B)
C
X

150